These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17561576)

  • 1. Medicine man. Interview by Richard M. Smith.
    Kindler J
    Newsweek; 2007 Apr; 149(16):E18. PubMed ID: 17561576
    [No Abstract]   [Full Text] [Related]  

  • 2. Wisdom from big pharma's Dr. Gloom. Interview by Abrahm Lustgarten.
    Garnier JP
    Fortune; 2005 Mar; 151(6):38. PubMed ID: 15782880
    [No Abstract]   [Full Text] [Related]  

  • 3. Merck's man in the hot seat.
    Simons J
    Fortune; 2004 Feb; 149(4):111-2, 114. PubMed ID: 14983668
    [No Abstract]   [Full Text] [Related]  

  • 4. Keys to CRM success. How well are contract pharmaceutical companies doing in the CRM game?
    Kros JF; Molis J
    Mark Health Serv; 2004; 24(4):32-6. PubMed ID: 15612224
    [No Abstract]   [Full Text] [Related]  

  • 5. Is it too late to save Schering?
    Simons J
    Fortune; 2003 Sep; 148(5):145-6, 148, 150. PubMed ID: 14509911
    [No Abstract]   [Full Text] [Related]  

  • 6. Can Merck stand alone?
    Warner M
    Fortune; 2001 Jul; 144(2):62. PubMed ID: 11471356
    [No Abstract]   [Full Text] [Related]  

  • 7. Effective executive management in the pharmaceutical industry.
    Tran H; Kleiner BH
    J Health Care Finance; 2005; 32(1):8-15. PubMed ID: 18972973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can J & J keep the magic going?
    Taylor A
    Fortune; 2002 May; 145(11):117-20, 122. PubMed ID: 12048959
    [No Abstract]   [Full Text] [Related]  

  • 9. An audience with... Paul Herrling. Interview by Joanna Owens.
    Herrling P
    Nat Rev Drug Discov; 2007 Mar; 6(3):180. PubMed ID: 17396288
    [No Abstract]   [Full Text] [Related]  

  • 10. Doesn't anyone know how to run a drug company?
    Simons J
    Fortune; 2005 Apr; 151(8):34. PubMed ID: 15852685
    [No Abstract]   [Full Text] [Related]  

  • 11. Designer drugs. What's best for patients isn't always what's best for profits.
    Sherrid P
    US News World Rep; 2001 Aug; 131(6):30-2. PubMed ID: 11508075
    [No Abstract]   [Full Text] [Related]  

  • 12. IT solutions for big Pharma's big headache.
    Krohn R
    J Healthc Inf Manag; 2005; 19(1):13-5. PubMed ID: 15682670
    [No Abstract]   [Full Text] [Related]  

  • 13. The $10 billion pill.
    Simons J
    Fortune; 2003 Jan; 147(1):58-62, 66, 68. PubMed ID: 12602122
    [No Abstract]   [Full Text] [Related]  

  • 14. Ichan the spoiler.
    Creswell J
    Fortune; 2005 Mar; 151(6):195-6, 198. PubMed ID: 15782883
    [No Abstract]   [Full Text] [Related]  

  • 15. Patent watch.
    Harrison C
    Nat Rev Drug Discov; 2008 Nov; 7(11):882-3. PubMed ID: 18974746
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preliminary analysis of ginseng industry in Wisconsin].
    Hu L; Zhang WS
    Zhongguo Zhong Yao Za Zhi; 2008 Jul; 33(14):1649-53. PubMed ID: 18841757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global consulting firm calls for revolution in drug marketing.
    Moynihan R
    BMJ; 2003 Aug; 327(7413):468. PubMed ID: 12946963
    [No Abstract]   [Full Text] [Related]  

  • 18. Peter Corr outlines Pfizer's approach to innovation, maximizing capabilities and delivering essential medicine. Interview by Steve Carney.
    Corr PB
    Drug Discov Today; 2005 Aug; 10(15):1017-20. PubMed ID: 16055016
    [No Abstract]   [Full Text] [Related]  

  • 19. Is there a market for personal medicine?
    Sherrid P
    US News World Rep; 2003 Jan; 134(2):56. PubMed ID: 12561698
    [No Abstract]   [Full Text] [Related]  

  • 20. Marketing groups merge. Rx communications pros get national organization.
    Robeznieks A
    Mod Healthc; 2007 Jun; 37(25):17. PubMed ID: 17824503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.